Cronos Group Soars 20.87% on Trump's Marijuana Reclassification Hopes

On August 11, 2025, Cronos Group's stock surged by 20.87% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

The recent surge in Cronos Group's stock price can be attributed to the potential reclassification of marijuana by the U.S. President Donald Trump. According to reports, Trump is considering downgrading marijuana to a less dangerous status, which could have far-reaching implications for the cannabis industry. This move, if implemented, would ease restrictions on marijuana, allow for tax breaks, and expand medical research, all of which are positive developments for companies like Cronos Group that operate in the cannabis sector.

Retail investors have been particularly bullish on cannabis stocks in response to these reports. The potential reclassification of marijuana to Schedule III would make it easier for companies to operate and expand their businesses, leading to increased investor interest and confidence in the sector. This optimism has translated into a significant rally for cannabis stocks, with Cronos Group being one of the notable beneficiaries.